Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Bad financial results growth rate -11.2% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-1.7%)
  • Dividend yield for the last twelve months 7.4%
  • Free cash flow yield 9.9% (LTM)
  • Share price is 7.1% higher than minimum and 57.6% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (12.2x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (-1.2%)23.12
year average price 26.69  


year start price 28.80 2024-06-06

max close price 31.39 2024-07-30

min close price 21.59 2025-04-10

current price 23.22 2025-06-05
Common stocks: 5 615 000 000

Dividend Yield:  7.4%
FCF Yield LTM: 9.9%
EV / LTM EBITDA: 12.2x
EV / EBITDA annualized: 9.9x
Last revenue growth (y/y):  -7.8%
Last growth of EBITDA (y/y):  -14.6%
Historical revenue growth:  -7.3%
Historical growth of EBITDA:  +3.9%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 129 819
Net Debt ($m): 45 091
EV (Enterprise Value): 174 910
EBITDA LTM ($m): 14 282
EV / LTM EBITDA: 12.2x
Price to Book: 1.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-06-03prnewswire.com

INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)

2025-06-03247wallst.com

3 Low-Priced Dividend Stocks Paying Over 5% Right Now

2025-06-01fool.com

Terrible News for Pfizer Stock Investors

2025-06-01247wallst.com

2 High-Yield Dividend Stocks Yielding Over 6% That'll Pay You to Wait

2025-05-31youtube.com

Pfizer (PFE) CEO on Braftovi Reducing Colorectal Cancer Death Risk "in Half"

2025-05-31reuters.com

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression

2025-05-29zacks.com

PFE or LLY: Which Is the Better Value Stock Right Now?

2025-05-27seekingalpha.com

Unlocking Pfizer's Value: Cost Controls And Oncology Pipeline

2025-05-26seekingalpha.com

Investing In The Promising PD1/VEGF Bispecific - Pfizer And Instil Could Be Good Candidates

2025-05-24fool.com

1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data